UNRESECTABLE EXTRAHEPATIC BILE DUCT CARCINOMA

Clinical trials for UNRESECTABLE EXTRAHEPATIC BILE DUCT CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new UNRESECTABLE EXTRAHEPATIC BILE DUCT CARCINOMA trials appear

Sign up with your email to follow new studies for UNRESECTABLE EXTRAHEPATIC BILE DUCT CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Major cancer trial tests if adding third drug helps fight tough bile duct cancers

Disease control Completed

This large, completed Phase 3 trial tested whether adding a third chemotherapy drug (nab-paclitaxel) to the standard two-drug treatment (gemcitabine and cisplatin) works better for people newly diagnosed with advanced cancers of the bile ducts, gallbladder, or liver. The study in…

Matched conditions: UNRESECTABLE EXTRAHEPATIC BILE DUCT CARCINOMA

Phase: PHASE3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control

Last updated Mar 30, 2026 14:27 UTC

UNRESECTABLE EXTRAHEPATIC BILE DUCT CARCINOMA

Get alerted when new UNRESECTABLE EXTRAHEPATIC BILE DUCT CARCINOMA trials appear

Major cancer trial tests if adding third drug helps fight tough bile duct cancers